Table 1 Key Demographic information for the CBTN and BraTS-PEDs cohorts
From: AI-powered segmentation and prognosis with missing MRI in pediatric brain tumors
BraTS-PEDs data | |
|---|---|
Number of Patients | 403 |
Histology | High-grade astrocytoma including DMG/DIPG |
CBTN data | |
Number of Patients | 312 |
Age (mean/median/std) in years | 9.3/8.5/5.4 |
Sex (Male/Female/Unknown) | 167(53%) /142(46%)/3(1%) |
Histology | Number (% of cohort) |
Low-grade glioma/astrocytoma (WHO grade I/II) | 172 (55.13%) |
Medulloblastoma | 90 (28.85%) |
DMG/DIPG | 23 (7.37%) |
Ependymoma, High-grade glioma/astrocytoma (WHO grade III/IV), Germinoma, Ganglioglioma, Craniopharungioma, Other, Meningioma, Sarcoma, Neurocytoma, Teratoma, Subependymal Giant Cell Astrocytoma (SEGA) | 27 (8.65%) |
Institution | Number (% of cohort) |
The Children’s Hospital of Philadelphia | 300 (96.15%) |
Seattle Children’s Hospital | 9 (2.88%) |
University of Pittsburgh | 2 (0.64%) |
Hackensack | 1 (0.32%) |
